Cavosonstat structure
|
Common Name | Cavosonstat | ||
---|---|---|---|---|
CAS Number | 1371587-51-7 | Molecular Weight | 299.708 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 527.5±50.0 °C at 760 mmHg | |
Molecular Formula | C16H10ClNO3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 272.8±30.1 °C |
Use of CavosonstatCavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat is a CFTR stabilizer, and can be used for cystic fibrosis research[1]. |
Name | Cavosonstat |
---|---|
Synonym | More Synonyms |
Description | Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat is a CFTR stabilizer, and can be used for cystic fibrosis research[1]. |
---|---|
Related Catalog | |
In Vitro | Cavosonstat (N91115), a CFTR modulator, promotes cystic fibrosis transmembrane conductance regulator (CFTR) maturation and plasma membrane stability, with a mechanism of action complementary to CFTR correctors and potentiators[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 527.5±50.0 °C at 760 mmHg |
Molecular Formula | C16H10ClNO3 |
Molecular Weight | 299.708 |
Flash Point | 272.8±30.1 °C |
Exact Mass | 299.034912 |
LogP | 4.28 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.715 |
3-Chloro-4-(6-hydroxy-2-quinolinyl)benzoic acid |
O2Z8Q22ZE4 |
UNII:O2Z8Q22ZE4 |
Cavosonstat |
10452 |
N91115 |
Benzoic acid, 3-chloro-4-(6-hydroxy-2-quinolinyl)- |